Skip to main content
Advertisement

Main menu

  • Home
  • Content
    • Current Issue
    • Accepted Manuscripts
    • Article Preview
    • Past Issue Archive
    • Video Articles
    • AJNR Case Collection
    • Case of the Week Archive
    • Case of the Month Archive
    • Classic Case Archive
  • Special Collections
    • AJNR Awards
    • ASNR Foundation Special Collection
    • Most Impactful AJNR Articles
    • Photon-Counting CT
    • Spinal CSF Leak Articles (Jan 2020-June 2024)
  • Multimedia
    • AJNR Podcasts
    • AJNR SCANtastic
    • Trainee Corner
    • MRI Safety Corner
    • Imaging Protocols
  • For Authors
    • Submit a Manuscript
    • Submit a Video Article
    • Submit an eLetter to the Editor/Response
    • Manuscript Submission Guidelines
    • Statistical Tips
    • Fast Publishing of Accepted Manuscripts
    • Graphical Abstract Preparation
    • Imaging Protocol Submission
    • Author Policies
  • About Us
    • About AJNR
    • Editorial Board
    • Editorial Board Alumni
  • More
    • Become a Reviewer/Academy of Reviewers
    • Subscribers
    • Permissions
    • Alerts
    • Feedback
    • Advertisers
    • ASNR Home

User menu

  • Alerts
  • Log in

Search

  • Advanced search
American Journal of Neuroradiology
American Journal of Neuroradiology

American Journal of Neuroradiology

ASHNR American Society of Functional Neuroradiology ASHNR American Society of Pediatric Neuroradiology ASSR
  • Alerts
  • Log in

Advanced Search

  • Home
  • Content
    • Current Issue
    • Accepted Manuscripts
    • Article Preview
    • Past Issue Archive
    • Video Articles
    • AJNR Case Collection
    • Case of the Week Archive
    • Case of the Month Archive
    • Classic Case Archive
  • Special Collections
    • AJNR Awards
    • ASNR Foundation Special Collection
    • Most Impactful AJNR Articles
    • Photon-Counting CT
    • Spinal CSF Leak Articles (Jan 2020-June 2024)
  • Multimedia
    • AJNR Podcasts
    • AJNR SCANtastic
    • Trainee Corner
    • MRI Safety Corner
    • Imaging Protocols
  • For Authors
    • Submit a Manuscript
    • Submit a Video Article
    • Submit an eLetter to the Editor/Response
    • Manuscript Submission Guidelines
    • Statistical Tips
    • Fast Publishing of Accepted Manuscripts
    • Graphical Abstract Preparation
    • Imaging Protocol Submission
    • Author Policies
  • About Us
    • About AJNR
    • Editorial Board
    • Editorial Board Alumni
  • More
    • Become a Reviewer/Academy of Reviewers
    • Subscribers
    • Permissions
    • Alerts
    • Feedback
    • Advertisers
    • ASNR Home
  • Follow AJNR on Twitter
  • Visit AJNR on Facebook
  • Follow AJNR on Instagram
  • Join AJNR on LinkedIn
  • RSS Feeds

AJNR is seeking candidates for the AJNR Podcast Editor. Read the position description.

Research ArticleAdult Brain

FLAIR Vascular Hyperintensities as a Surrogate of Collaterals in Acute Stroke: DWI Matters

L. Legrand, A. Le Berre, P. Seners, J. Benzakoun, W. Ben Hassen, S. Lion, G. Boulouis, J.-P. Cottier, V. Costalat, S. Bracard, Y. Berthezene, C. Ozsancak, C. Provost, O. Naggara, J.-C. Baron, G. Turc, C. Oppenheim and On behalf of the PREDICT-RECANAL Collaborators
American Journal of Neuroradiology January 2023, 44 (1) 26-32; DOI: https://doi.org/10.3174/ajnr.A7733
L. Legrand
aFrom the Institute of Psychiatry and Neuroscience of Paris (L.L., A.L.B., J.B., W.B.H., C.P., O.N., J.-C.B., G.T., C. Oppenheim), Université Paris Cité, Institut National de la Santé et de la Recherche Médicale U1266, Federation Hospitalo-Universitaire NeuroVasc, Paris, France
bDepartments of Neuroradiology (L.L., A.L.B., J.B., W.B.H., C.P., O.N., C. Oppenheim)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for L. Legrand
A. Le Berre
aFrom the Institute of Psychiatry and Neuroscience of Paris (L.L., A.L.B., J.B., W.B.H., C.P., O.N., J.-C.B., G.T., C. Oppenheim), Université Paris Cité, Institut National de la Santé et de la Recherche Médicale U1266, Federation Hospitalo-Universitaire NeuroVasc, Paris, France
bDepartments of Neuroradiology (L.L., A.L.B., J.B., W.B.H., C.P., O.N., C. Oppenheim)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for A. Le Berre
P. Seners
dDepartment of Neurology (P.S.), Hôpital Fondation Rothschild, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for P. Seners
J. Benzakoun
aFrom the Institute of Psychiatry and Neuroscience of Paris (L.L., A.L.B., J.B., W.B.H., C.P., O.N., J.-C.B., G.T., C. Oppenheim), Université Paris Cité, Institut National de la Santé et de la Recherche Médicale U1266, Federation Hospitalo-Universitaire NeuroVasc, Paris, France
bDepartments of Neuroradiology (L.L., A.L.B., J.B., W.B.H., C.P., O.N., C. Oppenheim)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for J. Benzakoun
W. Ben Hassen
aFrom the Institute of Psychiatry and Neuroscience of Paris (L.L., A.L.B., J.B., W.B.H., C.P., O.N., J.-C.B., G.T., C. Oppenheim), Université Paris Cité, Institut National de la Santé et de la Recherche Médicale U1266, Federation Hospitalo-Universitaire NeuroVasc, Paris, France
bDepartments of Neuroradiology (L.L., A.L.B., J.B., W.B.H., C.P., O.N., C. Oppenheim)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for W. Ben Hassen
S. Lion
eEdmus Services (S.L.), Fondation Edmus, Lyon, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
G. Boulouis
fDepartment of Diagnostic and Interventional Neuroradiology (G.B., J-.P.C.), Bretonneau Hospital, University of Tours, Institut National de la Santé et de la Recherche Médicale 1253 iBrain, Tours, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for G. Boulouis
J.-P. Cottier
fDepartment of Diagnostic and Interventional Neuroradiology (G.B., J-.P.C.), Bretonneau Hospital, University of Tours, Institut National de la Santé et de la Recherche Médicale 1253 iBrain, Tours, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for J.-P. Cottier
V. Costalat
gDepartment of Interventional Neuroradiology (V.C.), Centre Hospitalier Regional Universitaire Gui de Chauliac, Montpellier, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for V. Costalat
S. Bracard
hDepartment of Diagnostic and Interventional Neuroradiology (S.B.), University Hospital of Nancy, Institut National de la Santé et de la Recherche Médicale U947, Nancy, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for S. Bracard
Y. Berthezene
iDepartment of Neuroradiology (Y.B.), Hospices Civils de Lyon, Lyon, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Y. Berthezene
C. Ozsancak
jDepartment of Neurology (C. Ozsancak), Orleans Hospital, Orleans, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
C. Provost
aFrom the Institute of Psychiatry and Neuroscience of Paris (L.L., A.L.B., J.B., W.B.H., C.P., O.N., J.-C.B., G.T., C. Oppenheim), Université Paris Cité, Institut National de la Santé et de la Recherche Médicale U1266, Federation Hospitalo-Universitaire NeuroVasc, Paris, France
bDepartments of Neuroradiology (L.L., A.L.B., J.B., W.B.H., C.P., O.N., C. Oppenheim)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for C. Provost
O. Naggara
aFrom the Institute of Psychiatry and Neuroscience of Paris (L.L., A.L.B., J.B., W.B.H., C.P., O.N., J.-C.B., G.T., C. Oppenheim), Université Paris Cité, Institut National de la Santé et de la Recherche Médicale U1266, Federation Hospitalo-Universitaire NeuroVasc, Paris, France
bDepartments of Neuroradiology (L.L., A.L.B., J.B., W.B.H., C.P., O.N., C. Oppenheim)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for O. Naggara
J.-C. Baron
aFrom the Institute of Psychiatry and Neuroscience of Paris (L.L., A.L.B., J.B., W.B.H., C.P., O.N., J.-C.B., G.T., C. Oppenheim), Université Paris Cité, Institut National de la Santé et de la Recherche Médicale U1266, Federation Hospitalo-Universitaire NeuroVasc, Paris, France
cNeurology (J.-C.B., G.T.), Groupe Hospitalier Universitaire-Paris Psychiatrie et Neurosciences, Sainte-Anne Hospital, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for J.-C. Baron
G. Turc
aFrom the Institute of Psychiatry and Neuroscience of Paris (L.L., A.L.B., J.B., W.B.H., C.P., O.N., J.-C.B., G.T., C. Oppenheim), Université Paris Cité, Institut National de la Santé et de la Recherche Médicale U1266, Federation Hospitalo-Universitaire NeuroVasc, Paris, France
cNeurology (J.-C.B., G.T.), Groupe Hospitalier Universitaire-Paris Psychiatrie et Neurosciences, Sainte-Anne Hospital, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for G. Turc
C. Oppenheim
aFrom the Institute of Psychiatry and Neuroscience of Paris (L.L., A.L.B., J.B., W.B.H., C.P., O.N., J.-C.B., G.T., C. Oppenheim), Université Paris Cité, Institut National de la Santé et de la Recherche Médicale U1266, Federation Hospitalo-Universitaire NeuroVasc, Paris, France
bDepartments of Neuroradiology (L.L., A.L.B., J.B., W.B.H., C.P., O.N., C. Oppenheim)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for C. Oppenheim
  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • Responses
  • References
  • PDF
Loading

Abstract

BACKGROUND AND PURPOSE: FLAIR vascular hyperintensities are thought to represent leptomeningeal collaterals in acute ischemic stroke. However, whether all–FLAIR vascular hyperintensities or FLAIR vascular hyperintensities–DWI mismatch, ie, FLAIR vascular hyperintensities beyond the DWI lesion, best reflects collaterals remains debated. We aimed to compare the value of FLAIR vascular hyperintensities–DWI mismatch versus all–FLAIR vascular hyperintensities for collateral assessment using PWI-derived collateral flow maps as a reference.

MATERIALS AND METHODS: We retrospectively reviewed the registries of 6 large stroke centers and included all patients with acute stroke with anterior circulation large-vessel occlusion who underwent MR imaging with PWI before thrombectomy. Collateral status was graded from 1 to 4 on PWI-derived collateral flow maps and dichotomized into good (grades 3–4) and poor (grades 1–2). The extent of all–FLAIR vascular hyperintensities and FLAIR vascular hyperintensities–DWI mismatch was assessed on the 7 cortical ASPECTS regions, ranging from 0 (absence) to 7 (extensive), and associations with good collaterals were compared using receiver operating characteristic curves.

RESULTS: Of the 209 included patients, 133 (64%) and 76 (36%) had good and poor collaterals, respectively. All–FLAIR vascular hyperintensity extent was similar between collateral groups (P = .76). Conversely, FLAIR vascular hyperintensities–DWI mismatch extent was significantly higher in patients with good compared with poor collaterals (P < .001). The area under the curve was 0.80 (95% CI, 0.74–0.87) for FLAIR vascular hyperintensities–DWI mismatch and 0.52 (95% CI, 0.44–0.60) for all–FLAIR vascular hyperintensities (P < .001 for the comparison), to predict good collaterals. Variables independently associated with good collaterals were smaller DWI lesion volume (P < .001) and larger FLAIR vascular hyperintensities–DWI mismatch (P = .02).

CONCLUSIONS: In acute ischemic stroke with large-vessel occlusion, the extent of FLAIR vascular hyperintensities does not reliably reflect collateral status unless one accounts for DWI.

ABBREVIATIONS:

AIS
acute ischemic stroke
ASITN/SIR
American Society of Interventional and Therapeutic Neuroradiology/Society of Interventional Radiology
FVH
FLAIR vascular hyperintensities
HIR
hypoperfusion intensity ratio
IQR
interquartile range
IVT
IV thrombolysis
LVO
large-vessel occlusion
MT
mechanical thrombectomy
ROC
receiver operating characteristic
Tmax
time-to-maximum

Neuroimaging is critical for the diagnosis and triage for treatment of patients with acute ischemic stroke (AIS) due to large-vessel occlusion (LVO). Collateral status before treatment is an important determinant of tissue fate and response to treatment.1,2 Incorporation of collateral flow status into clinical decision-making may help determine eligibility for mechanical thrombectomy (MT),3 particularly in the delayed time window.4

Collateral grading on DSA is considered the criterion standard. It is based on both the extent and delay of retrograde perfusion, as per the American Society of Interventional and Therapeutic Neuroradiology/Society of Interventional Radiology (ASITN/SIR) score.5,6 This score has been adapted to collateral flow maps derived from PWI source data. These collateral flow maps have been validated against DSA, and provide greater parenchymal detail.2,7

Besides this advanced MR imaging technique for direct collateral flow imaging,2,7 routine MR images without contrast injection potentially provide valuable information regarding collateral status. On the FLAIR sequence, intracranial arteries normally appear dark due to the loss of signal intensity from the movement of blood. In case of an arterial occlusion, intracranial arteries become brighter, presumably because of the slow retrograde flow through leptomeningeal channels.8 These FLAIR vascular hyperintensities (FVH) are defined as focal, tubular, or serpentine hyperintensities in the subarachnoid space relative to CSF,9 corresponding to a typical arterial course. Although FVH have been proposed as a surrogate marker of collateral status,9 the relation between FVH and collateral status remains incompletely understood.10,11 Actually, FVH may not only represent retrograde collateral flow but also reflect slow anterograde flow or even stationary blood.

Collateral grading based on FVH commonly considers the extent of all FVH (all–FVH) in the affected territory; however, this lacks information regarding brain parenchyma, in contrast to both the ASITN/SIR DSA criterion standard and the PWI-derived collateral flow map–based grading scores. Critically, in the latter scores, parenchymal defect is a key item for distinguishing poor from good collaterals. Thus, the extent of all–FVH without consideration of the brain parenchyma may imperfectly reflect collateral adequacy. In contrast, assessing the presence of FVH beyond the DWI lesion, the so-called “FVH-DWI mismatch,” considers only the FVH associated with the at-risk but not yet irreversibly damaged tissue.12 Accordingly, the FVH-DWI mismatch has been previously used as an alternative to the PWI-DWI mismatch to assess the at-risk tissue12,13 and identify patients most likely to benefit from intravenous thrombolysis (IVT)14 or MT.15,16

On the basis of the above rationale, we hypothesized that the FVH-DWI mismatch is a better surrogate of collateral status than considering all–FVH. To test this hypothesis, we compared the value of the FVH-DWI mismatch versus all–FVH for collateral assessment using PWI-derived collateral flow maps as references.

MATERIALS AND METHODS

Study Design and Inclusion Criteria

All patients in the present study were included in a previous study that reported that good collaterals independently predict post-IVT recanalization before MT.1 In accordance with French legislation, each patient was informed of his or her participation in the latter study and was offered the possibility to withdraw. Because the study implied retrospective analysis of anonymized data collected as part of routine care, formal approval by an ethics committee was not required. This manuscript was prepared according to the Standards for Reporting Diagnostic Accuracy (STARD) statement.17 Data from 6 French stroke centers that perform PWI as part of routine admission imaging (Sainte-Anne [Paris], Hospices Civils [Lyon], Orléans, Tours, Montpellier, and Nancy University hospitals), extracted from a large French multicenter registry (PREDICT-RECANAL) of consecutive patients with LVO stroke referred for MT after IVT,18 were reviewed. Of note, the PWI data were not a basis for decision-making routinely, except in borderline cases.

The following inclusion criteria were used for this study: 1) acute stroke with LVO of the anterior circulation treated with IVT and referred for MT between May 2015 (when MT became routine care in these centers) and March 2017; and 2) pre-IVT MR imaging including DWI, FLAIR, T2*, MRA, and dynamic susceptibility contrast PWI to compute collateral flow maps (see below).

Data Acquisition

The following variables were extracted from the registries: age, sex, vascular risk factors, NIHSS score on admission, time between symptom onset and the start of MR imaging (onset-to-MR imaging time), and time between symptom onset and the start of IVT (onset-to-IVT time).

In line with French recommendations,19 MR imaging is implemented as first-line imaging in candidates for reperfusion therapy in all centers of the present study. Per inclusion criteria, the stroke MR imaging protocol included DWI, T2*, TOF-MRA, and dynamic susceptibility contrast PWI. FLAIR sequences were those routinely used in each center and were not standardized. The list of the main parameters of FLAIR sequences is presented in the Online Supplemental Data (all 2D FLAIR sequences).

A stroke neurologist (P.S. with 7 years of experience in stroke MR imaging) reviewed the pre-IVT imaging of all included patients. We collected the following variables: 1) occlusion site, according to 3 categories (intracranial ICA T or L occlusion and M1 and M2 segments of the MCA); 2) DWI lesion volume, semiautomatically segmented using Olea Sphere (Olea Medical) after applying a threshold of 620 × 10−6 mm2/s on ADC maps,20 with manual correction whenever necessary; and 3) hypoperfusion volumes, with time-to-maximum (Tmax) >4-, >6- and >10-second volumes, automatically segmented from PWI using Olea Sphere, with manual correction whenever necessary.21 Mismatch ratio was considered as a continuous variable and defined as Tmax > 6-second volume/DWI volume.22 It was further dichotomized using a 1.8 cutoff (PWI-DWI mismatch profile: Tmax > 6-second volume >1.8 × DWI volume).23 The hypoperfusion intensity ratio (HIR) was defined as Tmax > 10-second/Tmax > 6-second volume. The HIR reflects the proportion of severely hypoperfused tissue and is another surrogate for collaterals.24

PWI Collateral Flow Map Generation and Grading

The PWI acquisition parameters used in each participating center have been previously detailed.1 The collateral grading method used here is similar to that described in Kim et al.2 Briefly, this method uses the PWI raw data set and subtracts the baseline prebolus image from each frame of the raw perfusion data to automatically generate 3 sets of maps covering the MCA territory (early phase map, mid phase map, and late phase map, corresponding to the arterial, capillary, and venous phases of angiography, respectively) from which collaterals are visually graded from 1 to 4 on the basis of the ASITN/SIR angiographic classification,5,6 relying on the extension and the delay of retrograde perfusion: grade 1 (no or slow collaterals to the periphery of the ischemic site with persistence of some of the defect), grade 2 (rapid collaterals to the periphery of the ischemic site with persistence of some of the defect), grade 3 (collaterals with slow but complete angiographic blood flow of the ischemic bed by the late venous phase), and grade 4 (complete and rapid collateral blood flow to the vascular bed in the entire ischemic territory by retrograde perfusion).1,2,7 This technique has previously been validated against DSA2 and was used here as reference for collateral assessment. Of note, the reproducibility of collateral grading on PWI collateral flow maps was previously assessed in a random subset (n = 100); the weighted κ value for interrater agreement was 0.85 (95% CI, 0.76–0.93).1

Extent of FVH-DWI Mismatch and of All–FVH

FVH were defined as focal, tubular, or serpentine hyperintensities in the subarachnoid space relative to CSF,9 corresponding to a typical arterial course. On the basis of the 7 cortical ASPECTS regions,25 DWI and FLAIR sequences were rated for the presence or absence of DWI lesions and FVH by 1 radiologist (A.L.B. with 5 years of experience), blinded to the collateral grade. This rating allowed us to compute FVHASPECTS ranging from 0 (no FVH) to 7 (FVH abutting all cortical ASPECTS regions)26,27 and FVH-DWI mismatchASPECTS ranging from 0 (no FVH-DWI mismatch) to 7 (FVH-DWI mismatch in all cortical ASPECTS areas).12 To assess reproducibility, an experienced neuroradiologist (L.L. with 8 years of experience) independently reviewed a random subset (n = 100) of the sample. Figures 1 and 2 illustrate good and poor collaterals, respectively.

FIG 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIG 1.

Illustrative case of good collaterals. MR imaging of a patient around 60 years of age obtained 108 minutes after stroke onset. Hyperintense lesions in the left MCA territory on admission DWI (A) and FVH on admission FLAIR (B), with FVHASPECTS of 5 and FVH-DWI mismatchASPECTS of 4. Grade 4 collaterals on early phase (C), mid phase (D), and late phase (E) of collateral flow maps (subtracted dynamic susceptibility contrast perfusion imaging). Note complete and rapid (from mid phase) collateral blood flow to the vascular bed in the entire ischemic territory by retrograde perfusion.

FIG 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIG 2.

Illustrative case of poor collaterals. MR imaging of a patient around 70 years of age obtained 83 minutes after stroke onset. Hyperintense lesions in the left MCA territory on admission DWI (A) and FVH on admission FLAIR (B), with FVHASPECTS of 6 and FVH-DWI mismatchASPECTS of 1. Grade 2 collaterals on early phase (C), mid phase (D), and late phase (E) of collateral flow maps (subtracted dynamic susceptibility contrast perfusion imaging). Note rapid collaterals to the periphery of ischemic site with persistence of some of the defect (arrowheads).

Statistical Analysis

Categoric variables were described as number (percentage) and were compared using the χ2 or Fisher exact test. Continuous variables were described as means or median (interquartile range [IQR]) and compared using the Student t test or Mann-Whitney U test, as appropriate. The intraclass correlation coefficient was used to assess interobserver agreement for FVHASPECTS and FVH-DWI mismatchASPECTS. Correlations between collateral grades (1–4) and prespecified variables of interest (NIHSS, DWI lesion volume, PWI-DWI mismatch profile, and HIR) were assessed using the Spearman (ρ) coefficient. Associations between the dichotomized collateral status and FVH-DWI mismatchASPECTS or FVHASPECTS were assessed in univariable ordinal logistic regression and described as the common OR and its 95% CI, after verifying the assumption of proportional odds. Baseline variables at a level of P < .20 were candidates for inclusion in a multivariable binary logistic regression model, with good collaterals as the dependent variable. Variable selection was performed backwards using a stepwise approach, whereby candidate variables entered the model at P < .20 and were retained only if they remained associated at P < .05 with the dependent variable. Covariates were assessed for collinearity and interaction effects. To determine the predictive ability of FVH-DWI mismatch and all–FVH to assess collateral status, we calculated the area under the receiver operating characteristic (ROC) curve (ie, c-statistics). Statistical analyses were performed using SAS 9.4 (SAS Institute) and SPSS 19.0 (IBM). Two-tailed P < .05 was considered statistically significant.

RESULTS

Patient Characteristics, Collateral Grade, and Other Variables

Of the 224 patients reported in the princeps study,1 15 were excluded because MR imaging was not available (n = 4), lacked the FLAIR sequence (n = 8), or was affected by severe movement artifacts (n = 3), leaving 209 patients for the final analysis. Excluded patients were similar to included patients in terms of age (P = .21), sex (P = .46), NIHSS score (P = .40), occlusion site (P = .14), and collateral grade (P = .41). The baseline characteristics of included patients are presented in the Table. Grade 1 (poor) collaterals were present in 5 (2%); grade 2, in 71 (34%); grade 3, in 108 (52%); and grade 4 (excellent), in 25 (12%) patients. Given the small number of patients with grade 1 and 4 collaterals, grades 1–2 (poor collaterals) and grades 3–4 (good collaterals) were merged for subsequent analyses. A higher collateral grade was associated, as expected, with lower admission NIHSS scores (ρ = −0.29, P < .001), smaller DWI lesions (ρ = −0.61, P < .001), more frequent PWI-DWI mismatch profiles (96% versus 81%, P < .001), and lower HIR (ρ = −0.57, P < .001).

View this table:
  • View inline
  • View popup

Baseline characteristics of the population and univariate relationships with collateral gradea

Extent of FVH-DWI Mismatch and of All–FVH

Interobserver agreement for FVHASPECTS and FVH-DWI mismatchASPECTS was good, with intraclass correlation coefficients of 0.83 (95% CI, 0.75–0.89) for FVHASPECTS, in line with previous studies,26,27 and 0.89 (95% CI, 0.84–0.92) for FVH-DWI mismatchASPECTS. FVH-DWI mismatchASPECTS was significantly larger in patients with good compared with poor collaterals (median: 4 [IQR, 3–5] versus 2 [IQR, 0–2.75], P < .001). Conversely, FVHASPECTS was similar between the 2 groups (median: 5 [IQR, 4–5.5] in the good collaterals group versus 5 [IQR, 4–5] in the poor collaterals group, P = .76, Table). The common OR for good collaterals was 1.75 (95% CI, 1.48–2.06, P < .001) for the FVH-DWI mismatch and 1.00 (95% CI, 0.80–1.25, P = .98) for all–FVH. The area under the ROC curve to predict good collaterals was 0.80 (95% CI, 0.74-0.87) for FVH-DWI mismatch and 0.52 (95% CI, 0.44-0.60) for all–FVH (P < .001 for the comparison) (Fig 3). The cut-point of FVH-DWI mismatchASPECTS, maximizing the sum of sensitivity and specificity, was ≥3. By means of this cut-point, FVH-DWI mismatchASPECTS identified good collaterals with a sensitivity of 80% (95% CI, 72%–86%), specificity of 75% (95% CI, 64%–84%), a positive predictive value of 85% (95% CI, 77%–90%), and a negative predictive value of 68% (95% CI, 57%–77%). We verified post hoc that the results were similar by using the HIR instead of the PWI-derived collateral flow maps as an alternative surrogate for collaterals: HIR was dichotomized on the basis of its median value (0.43) into low (ie, good collaterals) versus high (ie, poor collaterals) subgroups. The area under the ROC curves to predict low HIR was 0.75 (95% CI, 0.68–0.81) for FVH-DWI mismatch and 0.53 (95% CI, 0.45–0.61) for all–FVH (P < .001 for the comparison). We also studied post hoc the correlations between FVHASPECTS/FVH-DWI mis matchASPECTS and perfusion deficits using Spearman (ρ) coefficients (Online Supplemental Data). The extent of all–FVH was associated with larger perfusion abnormalities (irrespective of the severity of the hypoperfusion). In contrast, the extent of the FVH-DWI mismatch was not correlated with Tmax > 4-second and Tmax > 6-second volumes but was negatively correlated with Tmax > 10-second volume and HIR, consistent with FVH-DWI mismatch reflecting good collaterals.

FIG 3.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIG 3.

ROC curves of FVH-DWI mismatchASPECTS (blue) and FVHASPECTS (red) to predict good (grades 3–4) collaterals. The area under the ROC curve was higher for FVH-DWI mismatchASPECTS (0.80; 95% CI, 0.74–0.87) than for FVHASPECTS (0.52; 95% CI, 0.44–0.60), P < .001 for comparison.

Multivariable Analysis

By means of good collaterals as the dependent variable, the multivariable model included 205 patients (132 with good collaterals and 73 without, after exclusion of 4 patients without PWI volumes). Variables included in the multivariable model were NIHSS score, DWI volume, Tmax > 6-second volume, and FVH-DWI mismatchASPECTS. Because of the collinearity among all PWI-derived metrics, only the Tmax > 6-second volume was entered in the model. Variables that remained independently associated with good collaterals were DWI volume (adjusted OR, 0.91; 95% CI, 0.87–0.94; P < .001) and FVH-DWI mismatchASPECTS (adjusted OR, 1.33; 95% CI, 1.04–1.70; P = .02); ie, patients with good collaterals had smaller DWI lesion volume and larger FVH-DWI mismatch.

DISCUSSION

In this large, multicentric population of patients with AIS referred for MT, we found, in line with our hypothesis, that the FVH-DWI mismatch is a reliable surrogate of collateral status and a better one than all–FVH. These findings emphasize the importance of taking into account the DWI lesion whenever FVH are used as a surrogate of collateral status.

Collaterals play a major role in stroke pathophysiology.28 These alternative vascular channels maintain perfusion to the ischemic tissue distal to the arterial occlusion, to a degree that depends on their strength. Accordingly, collateral status is a key determinant of the speed of core growth before recanalization2 and may be used for decision-making as a major treatment effect modifier.4 Although DSA remains the reference to assess collateral status, it is invasive; furthermore, exploration of all 4 arterial axes during MT is not systematically performed to save time, thereby hampering a comprehensive analysis of collaterals. Moreover, interobserver agreement of ASITN/SIR collateral grading on DSA has been reported by some to be poor.29 Finally, DSA provides information on collaterals once the patient is in the catheterization lab, which has a limited impact on the endovascular treatment workflow.

One strength of our study is the use of PWI for collateral assessment, as also reported by others.1,2,7,30 Contrary to DSA, grading on PWI-derived collateral flow maps has an almost perfect interobserver agreement.1,30 Moreover, PWI is performed within minutes of FLAIR, thereby providing information on collaterals almost simultaneous with FVH visualization. On the downside, PWI is not consistently part of acute stroke MR imaging because it requires additional scanning time, contrast agent administration and dedicated software. Thus, a straightforward pretreatment surrogate of collateral status would be useful in the clinical setting. This surrogate should be easily extractable from standard sequences whenever MR imaging is used for patient triage and should be directly assessable before patient transfer to the catheterization lab. FVH are such a promising candidate.

Our findings are consistent with accumulating evidence that FVH are a marker of adequate collaterality10 and, furthermore, that FVH beyond and those facing the DWI lesion have a different clinical significance,31 as recently highlighted in a study-level meta-analysis including 36 cohort studies involving >3500 patients.32 Studies that separately analyzed the FVH beyond versus those facing the DWI lesion found that the FVH pattern, not their sole extent or number, could serve as an imaging-selection criterion for endovascular therapy.31,33 Our study is the first to directly compare the 2 main methods of FVH assessment for collateral assessment in the same population. To this end, we used the same scoring approach based on ASPECTS regions for both all–FVH and FVH-DWI mismatch and found that good collaterals were associated solely with FVH-DWI mismatch extent. This finding relied on PWI-derived collateral flow maps to estimate collateral status and was confirmed post hoc using HIR as alternative collateral surrogate. Our finding is consistent with those in previous studies reporting that patients with an FVH-DWI mismatch have higher ASITN/SIR scores, ie, better collaterals than those without an FVH-DWI mismatch.34,35 These studies, however, considered the FVH-DWI mismatch as a binary variable compared with an ordinal one as used here. Samples used were small and overlapping, and interobserver reproducibility of collateral assessment on DSA was lacking.

Here we found no significant association between all–FVH extent and collateral grade, in contrast to some previous studies using DSA as a reference.36,37 However, the DSA-based studies used small samples, did not report interobserver reproducibility of DSA-based collateral assessment, and found no association between extensive all–FVH and smaller infarct size, which seems inconsistent. Using HIR rather than DSA before the MT era, a study found that all–FVH extent was associated with good collaterals.26 However, the FVH-DWI mismatch was not assessed in this monocenter study. Our multicenter study suggests that in patients referred for MT, the latter is a much better surrogate of collaterals than all–FVH. A score based on FVH-only might be more sensitive to data heterogeneity than a score based on the FVH-DWI mismatch, given that DWI lesion visibility is more straightforward than FVH, which are influenced by FLAIR parameters.38

Overall, the FVH facing and those beyond the DWI lesion may not share the same pathophysiology. In support, all–FVH had no prognostic value in 2 previous studies;31,39 furthermore, the presence of FVH within the DWI lesion was associated with subsequent hemorrhagic transformation.31 Considering this previous work together with our present findings, it would appear that all–FVH, though still widely used in recent prognostic studies,27,40 do not reliably reflect the collateral status in MT candidates and may, instead, represent variable degrees of perfusion abnormalities.

Our study has limitations. First, the multicenter registry used here was not designed for our analysis. Second, because our study included patients who underwent PWI, a selection bias cannot be excluded. However, patients excluded because of absent or poor-quality PWI did not differ from included patients in terms of age, NIHSS scores, and occlusion site.1 Third, MR images were mainly obtained within 4 hours of stroke onset, and results might differ at later time points when information on collaterals might be more useful for treatment decisions.10,11 Fourth, some patients were excluded because of FLAIR artifacts; however, this exclusion concerned <2% of the total sample. Fifth, although ratings of FVHASPECTS and FVH-DWI mismatchASPECTS remain subjective, interobserver agreement was good. Last, there were differences in FLAIR and DWI sequences among centers, which could have influenced the assessment of the FVH-DWI mismatch. Nevertheless, the prevalence of the FVH-DWI mismatch was similar across magnetic field strengths and manufacturers in a previous cohort,15 suggesting that it may be applied regardless of the MR imaging unit.

CONCLUSIONS

On the basis of a large multicenter population of patients with AIS and LVO who underwent MR imaging before MT, we show that the extent of the FVH-DWI mismatch is a good surrogate for collateral status and better than all–FVH. These findings support our hypothesis that the DWI lesion should be considered whenever FVH are used as surrogates for collaterals in this setting.

Acknowledgments

We thank Fatemehsadat Arzanforoosh for the collection of the technical parameters for FLAIR sequences in the participating centers.

Footnotes

  • Disclosure forms provided by the authors are available with the full text and PDF of this article at www.ajnr.org.

References

  1. 1.↵
    1. Seners P,
    2. Roca P,
    3. Legrand L, et al
    . Better collaterals are independently associated with post-thrombolysis recanalization before thrombectomy. Stroke 2019;50:867–72 doi:10.1161/STROKEAHA.118.022815 pmid:30908160
    CrossRefPubMed
  2. 2.↵
    1. Kim SJ,
    2. Son JP,
    3. Ryoo S, et al
    . A novel magnetic resonance imaging approach to collateral flow imaging in ischemic stroke. Ann Neurol 2014;76:356–69 doi:10.1002/ana.24211 pmid:24985162
    CrossRefPubMed
  3. 3.↵
    1. Powers WJ,
    2. Rabinstein AA,
    3. Ackerson T, et al
    . Guidelines for the Early Management of Patients with Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke—A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke 2019;50:e344–418 doi:10.1161/STR.0000000000000211 pmid:31662037
    CrossRefPubMed
  4. 4.↵
    1. Goyal M,
    2. Demchuk AM,
    3. Menon BK, et al
    ; ESCAPE Trial Investigators. Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med 2015;372:1019–30 doi:10.1056/NEJMoa1414905 pmid:25671798
    CrossRefPubMed
  5. 5.↵
    1. Higashida RT,
    2. Furlan AJ,
    3. Roberts H, et al
    ; Technology Assessment Committee of the Society of Interventional Radiology. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke. Stroke 2003;34:e109–37 doi:10.1161/01.STR.0000082721.62796.09 pmid:12869717
    Abstract/FREE Full Text
  6. 6.↵
    1. Zaidat OO,
    2. Yoo AJ,
    3. Khatri P, et al
    ; STIR Thrombolysis in Cerebral Infarction (TICI) Task Force. Recommendations on angiographic revascularization grading standards for acute ischemic stroke: a consensus statement. Stroke 2013;44:2650–63 doi:10.1161/STROKEAHA.113.001972 pmid:23920012
    FREE Full Text
  7. 7.↵
    1. Campbell BC,
    2. Christensen S,
    3. Tress BM, et al
    ; EPITHET Investigators. Failure of collateral blood flow is associated with infarct growth in ischemic stroke. J Cereb Blood Flow Metab 2013;33:1168–72 doi:10.1038/jcbfm.2013.77 pmid:23652626
    CrossRefPubMed
  8. 8.↵
    1. Sanossian N,
    2. Saver JL,
    3. Alger JR, et al
    . Angiography reveals that fluid-attenuated inversion recovery vascular hyperintensities are due to slow flow, not thrombus. AJNR Am J Neuroradiol 2009;30:564–68 doi:10.3174/ajnr.A1388 pmid:19022866
    Abstract/FREE Full Text
  9. 9.↵
    1. Azizyan A,
    2. Sanossian N,
    3. Mogensen MA, et al
    . Fluid-attenuated inversion recovery vascular hyperintensities: an important imaging marker for cerebrovascular disease. AJNR Am J Neuroradiol 2011;32:1771–75 doi:10.3174/ajnr.A2265 pmid:21051516
    Abstract/FREE Full Text
  10. 10.↵
    1. Lee KY,
    2. Kim JW,
    3. Park M, et al
    . Interpretation of fluid-attenuated inversion recovery vascular hyperintensity in stroke. J Neuroradiol 2022;49:258–66 doi:10.1016/j.neurad.2021.01.009 pmid:33515596
    CrossRefPubMed
  11. 11.↵
    1. Zeng L,
    2. Chen J,
    3. Liao H, et al
    . Fluid-attenuated inversion recovery vascular hyperintensity in cerebrovascular disease: a review for radiologists and clinicians. Front Aging Neurosci 2021;13:790626 doi:10.3389/fnagi.2021.790626 pmid:34975459
    CrossRefPubMed
  12. 12.↵
    1. Legrand L,
    2. Tisserand M,
    3. Turc G, et al
    . Do FLAIR vascular hyperintensities beyond the DWI lesion represent the ischemic penumbra? AJNR Am J Neuroradiol 2015;36:269–74 doi:10.3174/ajnr.A4088 pmid:25190202
    Abstract/FREE Full Text
  13. 13.↵
    1. Reyes D,
    2. Simpkins AN,
    3. Hitomi E, et al
    . Estimating perfusion deficits in acute stroke patients without perfusion imaging. Stroke 2022;53:3439–45 doi:10.1161/STROKEAHA.121.038101 pmid:35866426
    CrossRefPubMed
  14. 14.↵
    1. Legrand L,
    2. Tisserand M,
    3. Turc G, et al
    . Fluid-attenuated inversion recovery vascular hyperintensities-diffusion-weighted imaging mismatch identifies acute stroke patients most likely to benefit from recanalization. Stroke 2016;47:424–27 doi:10.1161/STROKEAHA.115.010999 pmid:26732567
    Abstract/FREE Full Text
  15. 15.↵
    1. Legrand L,
    2. Turc G,
    3. Edjlali M, et al
    ; THRACE Investigators. Benefit from revascularization after thrombectomy according to FLAIR vascular hyperintensities-DWI mismatch. Eur Radiol 2019;29:5567–76 doi:10.1007/s00330-019-06094-y pmid:30903341
    CrossRefPubMed
  16. 16.↵
    1. Wang Y,
    2. Zhou Z,
    3. Ding S
    . FLAIR vascular hyperintensity-DWI mismatch most likely to benefit from recanalization and good outcome after stroke. Medicine (Baltimore) 2020;99:e18665 doi:10.1097/MD.0000000000018665 pmid:31914055
    CrossRefPubMed
  17. 17.↵
    1. Bossuyt PM,
    2. Reitsma JB,
    3. Bruns DE, et al
    ; STARD Group. STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies. BMJ 2015;351:h5527 doi:10.1136/bmj.h5527 pmid:26511519
    FREE Full Text
  18. 18.↵
    1. Seners P,
    2. Turc G,
    3. Naggara O, et al
    ; PREDICT-RECANAL Collaborators. Post-thrombolysis recanalization in stroke referrals for thrombectomy: incidence, predictors, and prediction scores. Stroke 2018;49:2975–82 doi:10.1161/STROKEAHA.118.022335
    CrossRefPubMed
  19. 19.↵
    Haute Autorité de Santé. Stroke: early management (alert, prehospital phase, initial hospital phase, indications for thrombolysis). Clinical Practice Guidelines, 2009. https://www.has-sante.fr/upload/docs/application/pdf/2010-03/stroke_early_management_-_guidelines_-_english_version.pdf. Accessed June 29, 2022
  20. 20.↵
    1. Purushotham A,
    2. Campbell BC,
    3. Straka M, et al
    . Apparent diffusion coefficient threshold for delineation of ischemic core. Int J Stroke 2015;10:348–53 doi:10.1111/ijs.12068 pmid:23802548
    CrossRefPubMed
  21. 21.↵
    1. Seners P,
    2. Turc G,
    3. Lion S, et al
    . Relationships between brain perfusion and early recanalization after intravenous thrombolysis for acute stroke with large vessel occlusion. J Cereb Blood Flow Metab 2020;40:667–77 doi:10.1177/0271678X19836288 pmid:30890074
    CrossRefPubMed
  22. 22.↵
    1. Campbell BCV,
    2. Majoie C,
    3. Albers GW, et al
    ; HERMES Collaborators. Penumbral imaging and functional outcome in patients with anterior circulation ischaemic stroke treated with endovascular thrombectomy versus medical therapy: a meta-analysis of individual patient-level data. Lancet Neurol 2019;18:46–55 doi:10.1016/S1474-4422(18)30314-4 pmid:30413385
    CrossRefPubMed
  23. 23.↵
    1. Albers GW,
    2. Marks MP,
    3. Kemp S, et al
    ; DEFUSE 3 Investigators. Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging. N Engl J Med 2018;378:708–18 doi:10.1056/NEJMoa1713973 pmid:29364767
    CrossRefPubMed
  24. 24.↵
    1. Olivot JM,
    2. Mlynash M,
    3. Inoue M, et al
    ; DEFUSE 2 Investigators. Hypoperfusion intensity ratio predicts infarct progression and functional outcome in the DEFUSE 2 cohort. Stroke 2014;45:1018–23 doi:10.1161/STROKEAHA.113.003857 pmid:24595591
    Abstract/FREE Full Text
  25. 25.↵
    1. Barber PA,
    2. Demchuk AM,
    3. Zhang J, et al
    . Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy : ASPECTS Study Group—Alberta Stroke Programme Early CT Score. Lancet 2000;355:1670–74 doi:10.1016/S0140-6736(00)02237-6 pmid:10905241
    CrossRefPubMed
  26. 26.↵
    1. Mahdjoub E,
    2. Turc G,
    3. Legrand L, et al
    . Do fluid-attenuated inversion recovery vascular hyperintensities represent good collaterals before reperfusion therapy? AJNR Am J Neuroradiol 2018;39:77–83 doi:10.3174/ajnr.A5431 pmid:29074634
    Abstract/FREE Full Text
  27. 27.↵
    1. Lyu JH,
    2. Zhang SH,
    3. Wang XY, et al
    . FLAIR vessel hyperintensities predict functional outcomes in patients with acute ischemic stroke treated with medical therapy. Eur Radiol 2022;32:5436–45 doi:10.1007/s00330-022-08661-2 pmid:35278120
    CrossRefPubMed
  28. 28.↵
    1. Liebeskind DS
    . Collateral circulation. Stroke 2003;34:2279–84 doi:10.1161/01.STR.0000086465.41263.06 pmid:12881609
    Abstract/FREE Full Text
  29. 29.↵
    1. Ben Hassen W,
    2. Malley C,
    3. Boulouis G, et al
    . Inter- and intraobserver reliability for angiographic leptomeningeal collateral flow assessment by the American Society of Interventional and Therapeutic Neuroradiology/Society of Interventional Radiology (ASITN/SIR) scale. J Neurointerv Surg 2019;11:338–41 doi:10.1136/neurintsurg-2018-014185 pmid:30131382
    Abstract/FREE Full Text
  30. 30.↵
    1. Son JP,
    2. Lee MJ,
    3. Kim SJ, et al
    . Impact of slow blood filling via collaterals on infarct growth: comparison of mismatch and collateral status. J Stroke 2017;19:88–96 doi:10.5853/jos.2016.00955 pmid:28030891
    CrossRefPubMed
  31. 31.↵
    1. Liu D,
    2. Scalzo F,
    3. Rao NM, et al
    . Fluid-attenuated inversion recovery vascular hyperintensity topography, novel imaging marker for revascularization in middle cerebral artery occlusion. Stroke 2016;47:2763–69 doi:10.1161/STROKEAHA.116.013953 pmid:27659851
    Abstract/FREE Full Text
  32. 32.↵
    1. Zhou Z,
    2. Malavera A,
    3. Yoshimura S, et al
    . Clinical prognosis of FLAIR hyperintense arteries in ischaemic stroke patients: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry 2020;91:475–82 doi:10.1136/jnnp-2019-322625 pmid:32217786
    Abstract/FREE Full Text
  33. 33.↵
    1. Maruyama D,
    2. Yamada T,
    3. Murakami M, et al
    . FLAIR vascular hyperintensity with DWI for regional collateral flow and tissue fate in recanalized acute middle cerebral artery occlusion. Eur J Radiol 2021;135:109490 doi:10.1016/j.ejrad.2020.109490 pmid:33360270
    CrossRefPubMed
  34. 34.↵
    1. Zhou SB,
    2. Zhang XM,
    3. Gao Y, et al
    . Diffusion-weighted imaging volume and diffusion-weighted imaging volume growth in acute stroke: associations with fluid-attenuated inversion recovery hyperintensities-diffusion-weighted imaging mismatch and functional outcome. Neuroreport 2019;30:875–81 doi:10.1097/WNR.0000000000001291 pmid:31373966
    CrossRefPubMed
  35. 35.↵
    1. Jiang L,
    2. Peng M,
    3. Geng W, et al
    . FLAIR hyperintensities-DWI mismatch in acute stroke: associations with DWI volume and functional outcome. Brain Imaging Behav 2020;14:1230–37 doi:10.1007/s11682-019-00156-x pmid:31250263
    CrossRefPubMed
  36. 36.↵
    1. Nave AH,
    2. Kufner A,
    3. Bucke P, et al
    . Hyperintense vessels, collateralization, and functional outcome in patients with stroke receiving endovascular treatment. Stroke 2018;49:675–81 doi:10.1161/STROKEAHA.117.019588 pmid:29459394
    Abstract/FREE Full Text
  37. 37.↵
    1. Jiang L,
    2. Chen YC,
    3. Zhang H, et al
    . FLAIR vascular hyperintensity in acute stroke is associated with collateralization and functional outcome. Eur Radiol 2019;29:4879–88 doi:10.1007/s00330-019-06022-0 pmid:30762112
    CrossRefPubMed
  38. 38.↵
    1. Ahn SJ,
    2. Lee KY,
    3. Ahn SS, et al
    . Can FLAIR hyperintense vessel (FHV) signs be influenced by varying MR parameters and flow velocities? A flow phantom analysis. Acta Radiol 2016;57:580–86 doi:10.1177/0284185115592060 pmid:26124459
    CrossRefPubMed
  39. 39.↵
    1. Schellinger PD,
    2. Chalela JA,
    3. Kang DW, et al
    . Diagnostic and prognostic value of early MR imaging vessel signs in hyperacute stroke patients imaged <3 hours and treated with recombinant tissue plasminogen activator. AJNR Am J Neuroradiol 2005;26:618–24 pmid:15764589
    PubMed
  40. 40.↵
    1. Derraz I,
    2. Pou M,
    3. Labreuche J, et al
    ; ASTER and the THRACE Trials Investigators. Clot burden score and collateral status and their impact on functional outcome in acute ischemic stroke. AJNR Am J Neuroradiol 2021;42:42–48 doi:10.3174/ajnr.A6865 pmid:33184069
    Abstract/FREE Full Text
  • Received July 29, 2022.
  • Accepted after revision October 27, 2022.
  • © 2023 by American Journal of Neuroradiology
PreviousNext
Back to top

In this issue

American Journal of Neuroradiology: 44 (1)
American Journal of Neuroradiology
Vol. 44, Issue 1
1 Jan 2023
  • Table of Contents
  • Index by author
  • Complete Issue (PDF)
Advertisement
Print
Download PDF
Email Article

Thank you for your interest in spreading the word on American Journal of Neuroradiology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
FLAIR Vascular Hyperintensities as a Surrogate of Collaterals in Acute Stroke: DWI Matters
(Your Name) has sent you a message from American Journal of Neuroradiology
(Your Name) thought you would like to see the American Journal of Neuroradiology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Cite this article
L. Legrand, A. Le Berre, P. Seners, J. Benzakoun, W. Ben Hassen, S. Lion, G. Boulouis, J.-P. Cottier, V. Costalat, S. Bracard, Y. Berthezene, C. Ozsancak, C. Provost, O. Naggara, J.-C. Baron, G. Turc, C. Oppenheim, On behalf of the PREDICT-RECANAL Collaborators
FLAIR Vascular Hyperintensities as a Surrogate of Collaterals in Acute Stroke: DWI Matters
American Journal of Neuroradiology Jan 2023, 44 (1) 26-32; DOI: 10.3174/ajnr.A7733

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
0 Responses
Respond to this article
Share
Bookmark this article
FLAIR Hyperintensities and Collaterals in Stroke
L. Legrand, A. Le Berre, P. Seners, J. Benzakoun, W. Ben Hassen, S. Lion, G. Boulouis, J.-P. Cottier, V. Costalat, S. Bracard, Y. Berthezene, C. Ozsancak, C. Provost, O. Naggara, J.-C. Baron, G. Turc, C. Oppenheim, On behalf of the PREDICT-RECANAL Collaborators
American Journal of Neuroradiology Jan 2023, 44 (1) 26-32; DOI: 10.3174/ajnr.A7733
del.icio.us logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Purchase

Jump to section

  • Article
    • Abstract
    • ABBREVIATIONS:
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSIONS
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • Responses
  • References
  • PDF

Related Articles

  • PubMed
  • Google Scholar

Cited By...

  • Association between basal ganglia infarction and hemorrhagic transformation after mechanical thrombectomy in acute ischemic stroke: insights from the DIRECT-MT trial
  • Crossref (3)
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • Vascular hyperintensities on baseline FLAIR images are associated with functional outcome in stroke patients with successful recanalization after mechanical thrombectomy
    Alexandre Bani-Sadr, Raphaël Escande, Laura Mechtouff, Dylan Pavie, Marc Hermier, Laurent Derex, Tae-Hee Choc, Omer F. Eker, Norbert Nighoghossian, Yves Berthezène
    Diagnostic and Interventional Imaging 2023 104 7-8
  • Association between basal ganglia infarction and hemorrhagic transformation after mechanical thrombectomy in acute ischemic stroke: insights from the DIRECT-MT trial
    Rundong Chen, Weilong Hua, Yilei Zhang, Yongxin Zhang, Hongjian Zhang, Yongwei Zhang, Jianmin Liu, Pengfei Yang, Lei Zhang
    Journal of NeuroInterventional Surgery 2024
  • Genetic determinants of insufficiency of the collateral circulation
    James E Faber
    Journal of Cerebral Blood Flow & Metabolism 2025

More in this TOC Section

  • Diagnostic Neuroradiology of Monoclonal Antibodies
  • Clinical Outcomes After Chiari I Decompression
  • Segmentation of Brain Metastases with BLAST
Show more Adult Brain

Similar Articles

Advertisement

Indexed Content

  • Current Issue
  • Accepted Manuscripts
  • Article Preview
  • Past Issues
  • Editorials
  • Editor's Choice
  • Fellows' Journal Club
  • Letters to the Editor
  • Video Articles

Cases

  • Case Collection
  • Archive - Case of the Week
  • Archive - Case of the Month
  • Archive - Classic Case

Special Collections

  • AJNR Awards
  • ASNR Foundation Special Collection
  • Most Impactful AJNR Articles
  • Photon-Counting CT
  • Spinal CSF Leak Articles (Jan 2020-June 2024)

More from AJNR

  • Trainee Corner
  • Imaging Protocols
  • MRI Safety Corner

Multimedia

  • AJNR Podcasts
  • AJNR Scantastics

Resources

  • Turnaround Time
  • Submit a Manuscript
  • Submit a Video Article
  • Submit an eLetter to the Editor/Response
  • Manuscript Submission Guidelines
  • Statistical Tips
  • Fast Publishing of Accepted Manuscripts
  • Graphical Abstract Preparation
  • Imaging Protocol Submission
  • Evidence-Based Medicine Level Guide
  • Publishing Checklists
  • Author Policies
  • Become a Reviewer/Academy of Reviewers
  • News and Updates

About Us

  • About AJNR
  • Editorial Board
  • Editorial Board Alumni
  • Alerts
  • Permissions
  • Not an AJNR Subscriber? Join Now
  • Advertise with Us
  • Librarian Resources
  • Feedback
  • Terms and Conditions
  • AJNR Editorial Board Alumni

American Society of Neuroradiology

  • Not an ASNR Member? Join Now

© 2025 by the American Society of Neuroradiology All rights, including for text and data mining, AI training, and similar technologies, are reserved.
Print ISSN: 0195-6108 Online ISSN: 1936-959X

Powered by HighWire